CLINICAL FEATURES AND OUTCOME OF ACUTE HEPATITIS IN A TERTIARY CARE HOSPITAL, KARACHI

Authors

  • Dharamveer Pakistan. Author
  • Shabnam Naveed Jinnah Sindh Medical University, Karachi, Pakistan. Author
  • Uma Devi Pakistan. Author
  • Neha Rani , Pakistan. Author

DOI:

https://doi.org/10.71000/9mgsta94

Keywords:

Acute hepatitis, Complications, Hepatic Encephalopathy, Liver Function Tests, Prognosis, Risk Factors, Viral Hepatitis

Abstract

Background: Acute hepatitis is a significant global health problem and a frequent cause of liver-related morbidity. The disease can manifest as a mild, self-limiting illness or progress to severe complications such as hepatic encephalopathy, coagulopathy, or acute liver failure. In countries with limited resources, poor sanitation and unsafe medical practices contribute to its persistence, while diagnostic delays worsen clinical outcomes. Identifying demographic, clinical, and laboratory predictors of prognosis is essential to improve timely recognition, guide management, and reduce the burden of disease.

Objective: This study aimed to determine the demographic, clinical, and laboratory characteristics of patients with acute hepatitis and to evaluate the association of these factors with clinical outcomes.

Methods: A descriptive cross-sectional study was conducted at the Department of Medicine, Jinnah Postgraduate Medical Centre, Karachi, enrolling 105 patients aged 13 years and above with confirmed acute hepatitis. Patients with acute-on-chronic liver disease or malignancy were excluded. Data on demographics, clinical symptoms, laboratory parameters, complications, and outcomes were collected using structured questionnaires and proformas. Statistical analysis was performed with SPSS version 20. Frequencies and percentages were calculated for categorical variables, and Chi-square tests assessed associations with outcomes, considering p < 0.05 statistically significant.

Results: Of the 105 patients, 68 (64.8%) were male and 37 (35.2%) female. The most common age group was 25–34 years (30.5%), followed by 35–44 years (23.8%). Jaundice was reported in 82 patients (78.1%), fatigue in 70 (66.7%), and nausea or vomiting in 60 (57.1%). Elevated ALT >200 IU/L was found in 88 patients (83.8%), AST >200 IU/L in 83 (79.0%), and bilirubin >2 mg/dL in 72 (68.6%). Complications occurred in 37 patients (35.2%), with hepatic encephalopathy in 15 (14.3%), coagulopathy in 14 (13.3%), and acute liver failure in 8 (7.6%). Recovery was achieved in 88 patients (83.8%), prolonged hospital stay occurred in 12 (11.4%), and mortality was recorded in 5 (4.8%). Complications showed a strong association with poor outcomes (p < 0.001), while elevated INR indicated a borderline association (p = 0.09). Other demographic and laboratory factors did not significantly affect prognosis.

Conclusion: Acute hepatitis presents with non-specific symptoms but carries a substantial risk of severe complications that determine prognosis. Early recognition and management of hepatic encephalopathy and coagulopathy are vital to improving survival and reducing hospitalization.

Author Biographies

  • Dharamveer, Pakistan.

    PG Trainee, Pakistan.

  • Shabnam Naveed, Jinnah Sindh Medical University, Karachi, Pakistan.

    Professor & HOD, Jinnah Sindh Medical University, Karachi, Pakistan.

  • Uma Devi, Pakistan.

    Medical Officer, Pakistan.

  • Neha Rani, , Pakistan.

    Final Year MBBS Student, Pakistan.

References

Cortellazzo Wiel L, Spezzacatene A, Gortani G, Saccari A, Taddio A, Barbi E. Acute Acalculous Cholecystitis: Think of Hepatitis A Infection and Do Not Underestimate Pain. Pediatr Emerg Care. 2022;38(6):304-6.

Sterling RK, Wahed AS, Cloherty G, Hoofnagle JH, Lee WM. Acute Hepatitis B Virus Infection in North American Adults. Clin Gastroenterol Hepatol. 2023;21(7):1881-92.e4.

Jain J, Jain M. Acute liver failure in tropical infections- thinking beyond viral hepatitis! Trop Doct. 2023;53(1):137-9.

Muhammad SK, Shaikh BA, Gurbakshani KM, Jalbani AU. Frequency triple hepatitis (hepatitis B and C and D virus) in HBs Ag positive patients. Rawal Medical Journal. 1970 Jan 1;37(2):142-.

Ma Z, de Man RA, Kamar N, Pan Q. Chronic hepatitis E: Advancing research and patient care. J Hepatol. 2022;77(4):1109-23.

Yıldırım M, Öncel İ, Bektaş Ö, Tanalı G, Şahin S, Kutluk T, et al. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome. Eur J Paediatr Neurol. 2022;41:19-26.

Wang H, Wang J, Zhang S, Zhang S, Zhang Z, Liu J, et al. Clinical Features and Transition of Acute Hepatitis B Virus Infection. J Viral Hepat. 2025;32(2):e14048.

Choi JW, Kwak JY, Lee SS, Kim HG, Son HJ, Jeon H, et al. Clinical Features of Hepatitis C Virus-related Acute-on-chronic Liver Failure in a Korean Population. Korean J Gastroenterol. 2022;80(4):169-76.

Ghandili S, Lindhauer C, Pischke S, Zur Wiesch JS, Von Kroge PH, Polywka S, et al. Clinical features of hepatitis E infections in patients with hematologic disorders. Haematologica. 2022;107(12):2870-83.

You S, Zhu B, Xin S. Clinical Manifestations of Hepatitis E. Adv Exp Med Biol. 2023;1417:185-97.

Das S, Sood V, Rastogi A, Agarwal N, Kaul S, Yadav D, et al. Clinico-Pathological Spectrum of Hepatitis A Virus-Induced Autoimmune-Like Hepatitis in Children. J Viral Hepat. 2025;32(4):e14028.

Castaneda D, Gonzalez AJ, Alomari M, Tandon K, Zervos XB. From hepatitis A to E: A critical review of viral hepatitis. World J Gastroenterol. 2021;27(16):1691-715.

Westhoff M, Arias A, Litterst P. Hepatitis E and diaphragmatic dysfunction: Case series and review of the literature. Pneumologie. 2024;78(6):400-8.

Samala N, Abdallah W, Poole A, Shamseddeen H, V SA, E SO, et al. Insight into an acute hepatitis A outbreak in Indiana. J Viral Hepat. 2021;28(6):964-71.

Vadlapudi SS, Srivastava A, Rai P, Singh RK, Sarma MS, Poddar U, et al. Jaundice in a Child with Sickle Cell Anemia: A Case Based Approach. Indian J Pediatr. 2024;91(1):73-80.

Ripellino P, Lascano AM, Scheidegger O, Schilg-Hafer L, Schreiner B, Tsouni P, et al. Neuropathies related to hepatitis E virus infection: A prospective, matched case-control study. Eur J Neurol. 2024;31(1):e16030.

Bathobakae L, Bashir R, Wilkinson T, Phuu P, Koodirile A, Yuridullah R, et al. Non-hepatotropic viral hepatitis: a narrative review. Scand J Gastroenterol. 2024;59(12):1322-9.

Samanta A, Poddar U, Sen Sarma M, Srivastava A, Yachha SK, Mishra P. Persistent fever in acute hepatitis: think beyond acute viral hepatitis. Infect Dis (Lond). 2024;56(6):476-83.

Mehta S, John T, Feld JJ, Shah H, Mullaithilaga N, Campigotto A, et al. Severe acute hepatitis of unknown etiology in a large cohort of children. Hepatol Commun. 2023;7(10).

Biradar PA, Tambe AS, Rathi SP, Junare PR, Rathi PM. Spectrum of viral hepatitis in hospitalized children in western India. Trop Doct. 2023;53(1):109-12.

Hu Y, Zhang Y, Jiang W. Targeting hepatitis B virus-associated nephropathy: efficacy and challenges of current antiviral treatments. Clin Exp Med. 2025;25(1):57.

Nagra N, Kozarek RA, Burman BE. Therapeutic Advances in Viral Hepatitis A-E. Adv Ther. 2022;39(4):1524-52.

Cheung CKM, Wong SH, Law AWH, Law MF. Transfusion-transmitted hepatitis E: What we know so far? World J Gastroenterol. 2022;28(1):47-75.

Downloads

Published

2025-06-30